Skip to main content

Find Clinical Trials

Home
Conditions
Sebaceous Gland Diseases

Clinical trial condition

Sebaceous Gland Diseases

Explore clinical trials studying Sebaceous Gland Diseases. Study availability and eligibility vary by location and protocol.

655 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Sebaceous Gland Diseases trial results

Completed

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

NCT02465632

Conditions: Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations: Glenmark Investigational Site 13 Anaheim, California, United States

Glenmark Investigational Site 6 Long Beach, California, United States

Glenmark Investigational Site 15 Los Angeles, California, United States

Glenmark Investigational Site12 West Covina, California, United States

View all 15 locations

View Trial Details

Completed

A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris

NCT01019603

Conditions: Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations: DermResearch, Inc. Austin, Texas, United States

View Trial Details

Completed

Bioequivalence Minocycline Bioequivalence

NCT01755611

Conditions: Acne Vulgaris, Acneiform Eruptions, Cellulitis, +12 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

NCT01112787

Conditions: Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations: HillTop Research Corporation Scottsdale, Arizona, United States

View Trial Details

Completed

A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

NCT01115322

Conditions: Acne Vulgaris, Acneiform Eruptions, Dermatitis, +8 more
Locations: HillTop Research Corporation Scottsdale, Arizona, United States

View Trial Details

Completed

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

NCT01132443

Conditions: Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations: Not specified

View Trial Details

Completed

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

NCT01114841

Conditions: Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations: HillTop Research Corporation Scottsdale, Arizona, United States

View Trial Details

Completed

A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.

NCT01119651

Conditions: Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations: HillTop Research Corporation St. Petersburg, Florida, United States

View Trial Details

Completed

A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition

NCT02498288

Conditions: Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations: GSK Investigational Site Monterrey, Nuevo León, Mexico

View Trial Details

Completed

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

NCT00689117

Conditions: Acne, Acne Vulgaris, Acneiform Eruptions, +3 more
Locations: Radiant Research Birmingham, Alabama, United States

Coastal Clinical Research, Inc. Mobile, Alabama, United States

Burke Pharmaceutical Research Hot Springs, Arkansas, United States

Center for Dermatology, Cosmetic and Laser Surgery Fremont, California, United States

View all 32 locations

View Trial Details